Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eyes shut homolog (Drosophila) 9 pseudogene (ENSG00000272006)
- Target
- ENSG00000272006
- Molecular classification
- Pseudogene
01
Overview
Eyes shut homolog (Drosophila) 9 pseudogene (ENSG00000272006) is annotated as a pseudogene, which means it is a nonfunctional segment of DNA that originally derived from a functional gene but is now unable to encode a viable protein product. Pseudogenes in general are considered "genomic fossils": while they share sequence similarity with active genes, they typically lack promoters, contain frameshift or nonsense mutations, and have lost the ability to perform biological functions. Most pseudogenes, including this one, are not considered therapeutic targets, as they do not express protein products nor participate in molecular pathways relevant to pharmacological intervention. The presence of "pseudogene" in the name indicates, by definition, that this is not an active molecule and not a target for drug development or modulation. There is no evidence for drug interactions, disease associations, or measurable biological activity. This entry is incorrect as a target for therapeutic intervention, receptor biology, or drug discovery purposes.
- Other names
- Eyes shut homolog 9 pseudogeneEYS9 pseudogeneEyes shut homolog (Drosophila) 9 pseudogene
Beyond the preview
Go deeper on Eyes shut homolog (Drosophila) 9 pseudogene (ENSG00000272006).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Eyes shut homolog (Drosophila) 9 pseudogene (ENSG00000272006).